Sexual dysfunction and dissatisfaction in chronic hepatitis C patients.

Autor:	Fábregas BC; Programa de Pós-Graduação em Infectologia e Medicina Tropical, Faculdade Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, MG, BRAZIL., Moura AS; Faculdade de Medicina, Universidade José do Rosário Vellano, Belo Horizonte, MG, BRAZIL., Ávila RE; Centro de Treinamento e Referências em Doenças Infecciosas e Parasitárias Orestes Diniz, Secretaria Municipal de Saúde de Belo Horizonte e Universidade Federal de Minas Gerais, Belo Horizonte, MG, BRAZIL., Faria MN; Laboratório Interdisciplinar de Investigação Médica, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, MG, BRAZIL., Carmo RA; Centro de Treinamento e Referências em Doenças Infecciosas e Parasitárias Orestes Diniz, Secretaria Municipal de Saúde de Belo Horizonte e Universidade Federal de Minas Gerais, Belo Horizonte, MG, BRAZIL., Teixeira AL; Laboratório Interdisciplinar de Investigação Médica, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, MG, BRAZIL.
Jazyk:	angličtina
Zdroj:	Revista da Sociedade Brasileira de Medicina Tropical [Rev Soc Bras Med Trop] 2014 Sep-Oct; Vol. 47 (5), pp. 564-72.
DOI:	10.1590/0037-8682-0147-2014
Abstrakt:	Introduction: The prevalence of sexual dysfunction (SD) and dissatisfaction with sexual life (DSL) in patients with chronic hepatitis C virus infection (CHC) was jointly investigated via a thorough psychopathological analysis, which included dimensions such as fatigue, impulsiveness, psychiatric comorbidity, health-related quality of life (HRQL) and sociodemographic and clinical characteristics. Methods: Male and female CHC patients from an outpatient referral center were assessed using the Brief Fatigue Inventory, the Barrat Impulsiveness Scale, the Beck Depression Inventory (BDI), the Hospital Anxiety and Depression Scale, the Hamilton Anxiety Scale (HAM-A), and the World Health Organization Quality of Life Scale-Brief Version (WHOQOL-BREF). Structured psychiatric interviews were performed according to the Mini-International Neuropsychiatric Interview. SD was assessed based on specific items in the BDI (item 21) and the HAM-A (item 12). DSL was assessed based on a specific question in the WHOQOL-BREF (item 21). Multivariate analysis was performed according to an ordinal linear regression model in which SD and DSL were considered as outcome variables. Results: SD was reported by 60 (57.1%) of the patients according to the results of the BDI and by 54 (51.4%) of the patients according to the results of the HAM-A. SD was associated with older age, female gender, viral genotype 2 or 3, interferon-α use, impulsiveness, depressive symptoms, antidepressant and benzodiazepine use, and lower HRQL. DSL was reported by 34 (32.4%) of the patients and was associated with depressive symptoms, anxiety symptoms, antidepressant use, and lower HRQL. Conclusions: The prevalence of SD and DSL in CHC patients was high and was associated with factors, such as depressive symptoms and antidepressant use. Screening and managing these conditions represent significant steps toward improving medical assistance and the HRQL of CHC patients.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu